A detailed history of Nordea Investment Management Ab transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Nordea Investment Management Ab holds 2,482,169 shares of EW stock, worth $163 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
2,482,169
Previous 2,136,986 16.15%
Holding current value
$163 Million
Previous $204 Million 12.28%
% of portfolio
0.28%
Previous 0.25%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$84.3 - $94.31 $29.1 Million - $32.6 Million
345,183 Added 16.15%
2,482,169 $229 Million
Q1 2024

May 02, 2024

BUY
$72.54 - $95.56 $38.2 Million - $50.3 Million
526,574 Added 32.7%
2,136,986 $204 Million
Q4 2023

Jan 10, 2024

BUY
$61.71 - $77.76 $91.9 Million - $116 Million
1,488,791 Added 1224.12%
1,610,412 $123 Million
Q3 2023

Nov 13, 2023

SELL
$69.28 - $93.38 $194,884 - $262,677
-2,813 Reduced 2.26%
121,621 $8.43 Million
Q2 2023

Jul 07, 2023

SELL
$81.41 - $94.33 $129,441 - $149,984
-1,590 Reduced 1.26%
124,434 $11.7 Million
Q1 2023

Apr 19, 2023

BUY
$74.26 - $84.51 $42,922 - $48,846
578 Added 0.46%
126,024 $10.4 Million
Q4 2022

Feb 08, 2023

SELL
$68.3 - $87.44 $80,047 - $102,479
-1,172 Reduced 0.93%
125,446 $9.36 Million
Q3 2022

Oct 19, 2022

SELL
$82.37 - $107.29 $2.49 Million - $3.24 Million
-30,187 Reduced 19.25%
126,618 $10.7 Million
Q2 2022

Aug 09, 2022

SELL
$86.5 - $128.27 $3.13 Million - $4.64 Million
-36,141 Reduced 18.73%
156,805 $14.8 Million
Q1 2022

Apr 11, 2022

SELL
$101.96 - $128.34 $1.02 Million - $1.28 Million
-9,994 Reduced 4.92%
192,946 $23.1 Million
Q4 2021

Jan 20, 2022

SELL
$106.37 - $130.68 $434,840 - $534,219
-4,088 Reduced 1.97%
202,940 $26.5 Million
Q3 2021

Nov 01, 2021

SELL
$102.91 - $122.75 $21.3 Million - $25.4 Million
-207,028 Reduced 50.0%
207,028 $23.8 Million
Q3 2021

Nov 01, 2021

BUY
$102.91 - $122.75 $20.8 Million - $24.8 Million
201,912 Added 95.18%
414,056 $46.9 Million
Q2 2021

Jul 16, 2021

BUY
$83.84 - $104.76 $460,616 - $575,551
5,494 Added 2.66%
212,144 $22 Million
Q1 2021

May 17, 2021

BUY
$78.68 - $90.67 $345,562 - $398,222
4,392 Added 2.17%
206,650 $17.2 Million
Q4 2020

Feb 12, 2021

BUY
$71.69 - $91.23 $1.7 Million - $2.16 Million
23,664 Added 13.25%
202,258 $18.5 Million
Q3 2020

Nov 09, 2020

SELL
$67.19 - $87.44 $7.44 Million - $9.68 Million
-110,744 Reduced 38.27%
178,594 $14.1 Million
Q2 2020

Aug 13, 2020

BUY
$57.54 - $76.95 $13.9 Million - $18.5 Million
240,708 Added 494.98%
289,338 $20 Million
Q1 2020

May 15, 2020

SELL
$52.41 - $81.0 $72,220 - $111,618
-1,378 Reduced 2.76%
48,630 $9.36 Million
Q4 2019

Feb 11, 2020

SELL
$71.7 - $82.09 $18.5 Million - $21.2 Million
-258,158 Reduced 83.77%
50,008 $11.6 Million
Q3 2019

Nov 13, 2019

BUY
$61.55 - $75.43 $149,320 - $182,993
2,426 Added 0.79%
308,166 $67.3 Million
Q2 2019

Aug 14, 2019

BUY
$55.74 - $64.41 $26,643 - $30,787
478 Added 0.16%
305,740 $56.5 Million
Q1 2019

May 20, 2019

BUY
$47.89 - $64.05 $3.59 Million - $4.79 Million
74,860 Added 32.49%
305,262 $58.4 Million
Q4 2018

Feb 19, 2019

BUY
$46.41 - $56.94 $10.7 Million - $13.1 Million
230,402 New
230,402 $35.3 Million
Q4 2018

Feb 14, 2019

SELL
$46.41 - $56.94 $7.98 Million - $9.79 Million
-171,971 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$45.7 - $58.03 $901,615 - $1.14 Million
-19,729 Reduced 10.29%
171,971 $29.9 Million
Q2 2018

Aug 13, 2018

BUY
$42.45 - $51.3 $7.73 Million - $9.34 Million
182,072 Added 1891.07%
191,700 $27.9 Million
Q1 2018

May 14, 2018

SELL
$37.19 - $47.45 $4,797 - $6,121
-129 Reduced 1.32%
9,628 $1.34 Million
Q4 2017

Feb 12, 2018

SELL
$33.79 - $39.39 $14,935 - $17,410
-442 Reduced 4.33%
9,757 $1.1 Million
Q3 2017

Nov 09, 2017

BUY
$36.29 - $38.83 $370,121 - $396,027
10,199
10,199 $1.12 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Nordea Investment Management Ab Portfolio

Follow Nordea Investment Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.